Hememics to Showcase Rapid Point of Care Biosensor System at 2023 AACC Expo in Anaheim, CA
The Hememics technology uses graphene-based sensors alongside patented bio-preservatives. Its rugged handheld device consists of an easy-to-use reader, built on a biochip with 32 sensors. The sensors can be individually programmed to detect molecular, antigen and antibody targets, enabling a variety of tests.
One of the key advantages of the Hememics biosensor system is its networking capability, which allows for real-time reporting of results to relevant health agencies. This feature is essential in cases of environmental contamination, where quick detection and response can be critical to safeguarding human health.
The Hememics biosensor system is also designed for easy and intuitive use, requiring minimal training and expertise. Its portability allows for use in remote or resource-limited areas, making it an ideal solution for field testing.
"We are excited to showcase our latest biosensor system at the AACC Expo," said Hememics CEO John Warden. "Our biosensor system represents a significant step forward in the rapid and accurate detection of environmental toxins. Its portability, ease of use, and networking capability make it an essential tool for researchers, farmers, and public health agencies."
Visit booth #1395 at the AACC Expo to see the Hememics biosensor system in action and learn more about its capabilities in detecting environmental toxins in water, soil, and agricultural products. For more information about Hememics and their rapid point-of-care biosensor system, please visit their website at www.hememics.com.
About Hememics Biotechnologies, Inc.
Hememics uniquely uses graphene-based sensors with our patented bio preservatives to bring handheld, lab-quality testing performance to wherever needed – whether it is a farm, emergency room or battlefield. Our rugged, low-cost platform consists of a portable, easy-to-use reader utilizing a single-use biochip with 32 sensors. Our sensors can be individually programmed to detect molecular, antigen and antibody targets. We put a whole lab in your hand so you can make decisions when and wherever necessary – simplifying workflows with results within 5 minutes.
Media Contact: John Warden, Jr.
info@hememics.com
240-800-1113
Richard Liu
Hememics Biotechnologies, Inc.
+1 240-800-1113
Info@hememics.com
